SCHEMBL7177404

SCHEMBL7177404

O=C(c1cc2cc(O)c(O)cc2[nH]1)N1CCC(Cc2ccccc2)CC1

nearest known ligand 0.78

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 6/20 0.78
GRIN3B O60391 6/20 0.78
GRIN1 Q05586 6/20 0.78
GRIN2A Q12879 6/20 0.78
GRIN2B Q13224 6/20 0.78
GRIN2C Q14957 6/20 0.78
GRIN3A Q8TCU5 6/20 0.78
MEN1 O00255 4/20 0.74
KMT2A Q03164 4/20 0.74
NPC1 O15118 1/20 0.69
MAPT P10636 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7169445 0.89 MEN1 (0.87) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7158932 0.88 GRIN2D (1.00) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL4813274 0.88 GRIN2D (1.00) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL2195472 0.87 GRIN2D (0.79) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL30301395 0.87 GRIN2D (0.79) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL4812308 0.87 GRIN2D (0.72) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL4812389 0.84 GRIN2D (0.78) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7154105 0.84 MEN1 (0.80) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7158407 0.83 GRIN2D (1.00) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL4812991 0.82 GRIN2D (0.66) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1328514-A1 AMIDE DERIVATIVES AS NMDA RECEPTOR ANTAGONISTS RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 2003-07-23 EP disclosed
WO-2002034718-A1 AMIDE DERIVATIVES AS NMDA RECEPTOR ANTAGONISTS RICHTER GEDEON VEGYESZETI GYAR RT. (HU) 2002-05-02 WO disclosed